Target intelligence / Profile preview

Host cell receptors for measles virus entry

Molecular classification
Receptor, Cell adhesion molecule, Complement regulatory protein, Immunoglobulin superfamily
01

Overview

The host cell receptors for measles virus entry are a group of cell surface proteins that facilitate the infection of various human tissues by the measles virus (MeV) (Lin et al., 2016). The primary receptor for wild-type MeV on immune cells is Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1, also known as CD150), which is expressed on activated T and B cells, dendritic cells, and macrophages (Lin et al., 2016; Muhlebach et al., 2012). For infection of epithelial cells, the virus utilizes Nectin-4 (PVRL4), an adherens junction protein that also serves as a significant biomarker and therapeutic target in several adenocarcinomas (Muhlebach et al., 2011). Additionally, vaccine and laboratory-adapted strains of MeV can utilize Membrane Cofactor Protein (CD46), a complement regulatory protein found on all nucleated cells (Gerlier et al., 1995). These receptors interact with the viral hemagglutinin (H) protein, which subsequently triggers the fusion (F) protein to mediate membrane merger and viral entry (Plemper et al., 2004). Beyond their role in infection, these receptors are targets for novel therapies, such as the antibody-drug conjugate enfortumab vedotin for Nectin-4-positive cancers and experimental entry inhibitors like AS-48 for measles treatment (Plemper et al., 2004; ASCO Daily News, 2020). Targeting these receptors or the viral proteins that bind to them is a key strategy for developing antivirals and oncolytic therapies (Muhlebach et al., 2011; BioWorld, 2024).

Other names
Signaling lymphocytic activation molecule family member 1SLAMF1CD150Nectin-4PVRL4Poliovirus receptor-related 4Membrane cofactor proteinCD46Measles virus receptors
02

Mechanism of action

Inhibition of viral attachment, inhibition of membrane fusion, receptor blockade, and antibody-drug conjugate-mediated cytotoxicity.

03

Biological functions

Viral entryImmune responseCell-cell adhesionComplement regulationAutophagy regulation
04

Disease associations

InfectionCancerInflammation
05

Safety considerations

Skin toxicityNeutropeniaImmunosuppressionComplement-mediated tissue damage
06

Interacting drugs

Enfortumab vedotin

4 more in the full profile.

07

Biomarkers

SLAMF1 expressionNectin-4 expressionCD46 expression

Beyond the preview

Go deeper on Host cell receptors for measles virus entry.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell receptors for measles virus entry.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call